The Milan System for Reporting Salivary Gland Cytopathology
Beschreibung:
Dr. Esther Diana Rossi received an MD followed by a residency in Anatomic Pathology and a PhD from the Catholic University in Rome, Italy. She was an international observer in surgical pathology and cytopathology at the University of Pennsylvania and Hahnemann University (both in Philadelphia), Gustave Roussy (Paris), and the Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP). Dr. Rossi is currently the Director of Cytopathology and Endocrine Pathology at the Fondazione Policlinico Universitario Agostino Gemelli IRCCS and an Associate Professor of Pathology at Catholic University, also with the title of Full Professor. She has published more than 200 original articles, reviews, and book chapters on endocrine pathology, cytology, and head and neck pathology. Dr. Rossi has co-authored 6 books and served as co-editor of the Milan System for Reporting Salivary Gland Cytopathology, as well as for the upcoming second edition. She also served as one of the three lead authors for the revisions to the Bethesda Thyroid FNA Classification System second edition and is the lead author for the chapter on undifferentiated carcinoma for the upcoming third edition. Dr. Rossi contributed chapters to the WHO Classifications of Endocrine and Neuroendocrine Tumors, Head and Neck Tumors, Pediatric Tumors, and Tumors of Hematopoietic and Lymphoid Tissues. She has delivered numerous lectures, workshops, and short courses at national and international meetings including USCAP, ASC, ASCP, CAP, ECC, ICC, ESP, IAP, and SIAPEC. Dr. Rossi is Associate Editor of Cancer Cytopathology and a member of the editorial boards of Diagnostic Cytopathology, Cytojournal, Acta Cytologica, PLOS One, Endocrine Pathology, and the Journal of the American Society of Cytopathology. She serves on the executive board of the Papanicolaou Society, the Scientific Committee of the EFCS and the abstract review board for the USCAP. Dr. Rossi has received awards from the Italian Society of Pathology, the American Society of Cytopathology, and the Italian Cancer Program-AIRC.
Dr. Zubair Baloch received his medical degree from Liaquat Medical University in Hyderabad, Sind, Pakistan. After receiving his PhD in 1991 he joined the pathology residency at Hahnemann University Hospital. This was followed by fellowships in surgical pathology at Memorial Sloan Kettering Cancer Center, New York and cytopathology at the University of Pennsylvania Medical Center, Philadelphia under the mentorship of Dr. Prabodh K. Gupta (past president ASC). Dr. Baloch began his career as an assistant professor in the Department of Pathology & Laboratory Medicine at UPENN medical center in1997an
The Second Edition of The Milan System for Reporting Salivary Gland Cytopathology, like the First Edition, represents a collaborative effort by a multidisciplinary group of cytopathologists, surgical pathologists, molecular pathologists, radiologists, and head and neck surgeons. This international group shares the goal of creating a practical and uniform reporting system for salivary gland fine needle aspiration (FNA). This book is organized into six general diagnostic categories: "Non-Diagnostic," "Non-Neoplastic," "Atypia of Undetermined Significance (AUS)," "Neoplasm: Benign," "Neoplasm: Salivary Gland Neoplasm of Uncertain Malignant Potential (SUMP)," "Suspicious for Malignancy," and "Malignant." It includes definitions, morphologic criteria, and explanations for each of the diagnostic categories. Specific chapters are dedicated to the application of the latest available ancillary studies, radiologic features of salivary gland lesions, clinical management, and histological considerations including updates from the most recent 5th Edition WHO blue book.
The Milan System for Reporting Salivary Gland Cytopathology 2nd Edition represents an essential step towards increasing the overall effectiveness of salivary gland FNA and fostering better communication between clinicians and between institutions to improve overall patient care.